Hamish Baillie appointed a NED at Fidelity Special Values from 1 Jan 2026

Fidelity

Fidelity Special Values Plc (LON:FSV) has announced the appointment of Hamish Baillie as a non-executive Director of the Company with effect from 1 January 2026. Hamish will also serve as a member of the Audit, Management Engagement and Nomination Committees of the Board.

Hamish is non-executive Director and Senior Independent Director and Chairman of the Management Engagement Committee of The Biotech Growth Trust plc. He is also non-executive Director and Senior Independent Director of Mid Wynd International Investment Trust plc. He has extensive executive and non-executive experience in managing investment trusts.

Hamish’s executive career was spent at Ruffer LLP, which he joined in 2002 and became a partner in 2006. He was a member of the leadership team overseeing UK Wealth Management, including retail and platform investors. Between 2011 and 2022 he was the Lead Manager of Ruffer Investment Company Ltd.  He founded and managed the Edinburgh office of Ruffer and held firm-wide responsibilities in relation to portfolio management and investor communications.  He was also a director of Ruffer (Channel Islands) Limited.  He retired from Ruffer in October 2022.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

UK shares gain as lower bond yields support sentiment

UK shares rose as gilt yields fell, while updates from WPP, Haleon, Vodafone and Hilton Food Group created fresh company-specific catalysts.

Fidelity Special Values gains 11.8% YTD as UK investor sentiment improves

Fidelity Special Values PLC reported a 20.7% NAV return for the 12 months to 31 July 2026, while its share price rose 25.3% against a 21.6% benchmark return. Managers continue to see attractive opportunities in undervalued UK mid and smaller companies.

FTSE 100 draws support from miners ahead of key market events

Mining shares are supporting the FTSE 100 as markets prepare for Iran sanctions, Nvidia results and signals from the Federal Reserve.

UK value offers a clearer opportunity as AI changes the market

Alex Wright of Fidelity Special Values discusses with Kepler Partners why UK valuations, selective stock picking and the impact of AI continue to shape the opportunity set.

FTSE 100 gains support from miners, AstraZeneca and Rolls-Royce

Miners, AstraZeneca and Rolls-Royce supported the FTSE 100 as markets prepared for UK employment and inflation data that could influence interest-rate expectations.

Watch Fidelity present investments in UK, Europe, Emerging Markets, Asia and China (video)

Fidelity Investment Companies Forum 2026 brings together leading Portfolio Managers to discuss global markets, investment opportunities, AI, valuations and long-term investing.

Search